Non-invasive Point-of-care Diagnosis Using Machine Learning and Signal Analytics to Transform Early Detection of Heart Disease (IDENTIFY)

Analytics For Life

Status: Unknown

Conditions: Coronary Artery Disease

Treatments: Device: Phase Signal Recorder

Study type: Interventional

Funder types: Industry

Identifiers

NCT03864081

CADF-CIP-001

Details and patient eligibility

About

This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to coronary angiography. The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by Analytics 4 Life.

Full description

Male and Female subjects will be uniquely and consecutively enrolled into one of two groups to support populating a repository of phase signals: Group 1: Subjects with known prior coronary artery disease or previous percutaneous coronary intervention (PCI), and Group 2: Subjects with new onset symptoms suggestive of obstructive coronary artery disease at current presentation with no known coronary artery disease.

Enrollment into Group 1 and Group 2 will occur simultaneously until up to 500 male subjects and up to 1000 female subjects with paired data (phase signal and coronary angiography outcomes data) are enrolled. Once the desired number of subjects have been enrolled from both groups, then only Group 2 will continue to be enrolled.

Resting phase signals will be collected in all patients who meet inclusion/exclusion criteria and have signed an informed consent form. This study consists of a screening visit, resting phase signal collection (study procedure), and coronary angiography. In this study, resting phase signals will be acquired in subjects prior to coronary angiography.

Enrollment: 2,500 estimated patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients ≥ 18 years old;
2. Symptoms suggestive of obstructive CAD;
3. Scheduled to undergo cardiac catheterization with coronary angiography;
4. Ability to understand the requirements of the study and to provide written informed consent.

Exclusion criteria

1. Prior documented history of myocardial infarction (MI);
2. Suspected acute myocardial infarction (AMI) at current presentation;
3. Prior coronary artery bypass grafting (CABG);
4. Prior heart valve replacement;
5. Previous sustained or paroxysmal atrial or ventricular arrythmia;
6. Infiltrative myocardial disease (amyloid, sarcoid, right ventricular dysplasia);
7. Presence of cardiac implantable electronic device (CIED), including implantable cardioverter defibrillator (ICD), pacemaker (PM), implantable loop recorders and other monitors;
8. Implantable Neuro-stimulators;
9. Congenital Heart Disease;
10. Pregnant or breast feeding;
11. Currently taking any Type IA, IC or III antiarrhythmics;
12. Any history of amiodarone use;
13. Clinically significant chest deformity (e.g., pectus excavatum or pectus carinatum);
14. Breast implants;
15. Neuromuscular Disease if the condition results in tremor or muscle fasciculations.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2,500 participants in 1 patient group

Enrolled Subjects (PSR)

Other group

Description:

Patients who meet the study's inclusion and exclusion criteria, including signing the informed consent form, subjects will undergo signal acquisition prior to their scheduled cardiac catheterization on the day of the procedure.

Treatment:

Device: Phase Signal Recorder